GLOW consortium utilised LaRDR data in a prognostic model

News, Newsletter March 27, 2024

Congratulations to Dr Michael Binkley and other investigators who utilised LaRDR data in the International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin…

Read More

Early view of the GELF criteria study published on Haematologica

News, Newsletter March 26, 2024

Congratulations to Dr Allison Barraclough, and other investigators who published an early view version of the Impact and utility of…

Read More

7500th patient recruitment

News, Newsletter March 16, 2024

Congratulations to all participating sites at the Lymphoma and Related Diseases Registry (LaRDR) for enrolling the 7500th patient on March 14, 2024. We would like…

Read More

LaRDR supports Rare Disease Day 2024

News, Newsletter February 28, 2024

We acknowledge the research participation and support provided by patients, carers and their clinicians. We continue to provide a national…

Read More

Polatuzumab manuscript published on ejHaem

News, Newsletter February 26, 2024

Congratulations to Dr Briony Shaw, Ms Eliza Chung and other investigators who utilised LaRDR data to analyse outcomes of relapsed/ refractory…

Read More

7000th patient recruitment

News, Newsletter January 17, 2024

Congratulations to all participating sites at the Lymphoma and Related Diseases Registry (LaRDR) for enrolling the 7000th patient on January 4, 2024. We would like…

Read More

December 2023 newsletter is here.

New Sites, News, Newsletter December 1, 2023

Click here to read our December newsletter. Leave us a message if you would like to join the subscription list for future…

Read More

Thank you for attending the Hybrid Lymphoma Breakfast Meeting 2023!

Investigator Meeting, News, Newsletter November 21, 2023

The Lymphoma Breakfast Meeting co-hosted by the Australasian Lymphoma Alliance, Lymphoma and Related Diseases Registry, and Lymphoma Australia was a…

Read More

LaRDR at BLOOD Conference 2023!

News, Newsletter November 21, 2023

LaRDR showcased our research output in BLOOD in a poster presentation. Ms Eliza Chung presented the analysis of polatuzumab in relapsed…

Read More

ASH abstracts 2023

News, Newsletter November 1, 2023

The HoLISTIC Consortium which LaRDR participates and contributes data has two posters on the Identification of Risk Categories from the Advanced-Stage…

Read More